¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"specific antiserum"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
antiserum
Ç×Ç÷û
horse antiserum thymocyte
¸»Ç×Ç÷û°¡½¿»ù¼¼Æ÷, ¸»Ç×Ç÷ûÈä¼±¼¼Æ÷
age-specific death rate
¿¬·Éº°»ç¸Á·ü
age-specific fertility rate
¿¬·Éº°»ý½Ä·ü
age-specific rate
¿¬·Éº°ºñÀ²
cause-specific rate
¿øÀκ°ºñÀ²
donor-specific phage
Á¦°øÀÚÆ¯ÀÌÆÄÁö, °ø¿©ÀÚÆ¯ÀÌÆÄÁö
granulocyte-specific antigen
°ú¸³±¸Æ¯ÀÌÇ׿ø
group-specific
±ºÆ¯ÀÌ-
group-specific antigen
¹«¸®Æ¯ÀÌÇ׿ø, ±ºÆ¯ÀÌÇ׿ø
neuron-specific enolase
´º·±Æ¯ÀÌ¿¡³î¶ó¾ÆÁ¦
organ specific antigen
Àå±âƯÀÌÇ׿ø
platelet-specific antigen
Ç÷¼ÒÆÇƯÀÌÇ׿ø
prostate specific antigen
Àü¸³»ùƯÀÌÇ׿ø
species-specific
Á¾Æ¯ÀÌ-
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
6
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
antiserum
Ç×Ç÷û
platelet-specific antigen
Ç÷¼ÒÆÇƯÀÌÇ׿ø
specific activity
ºñ¹æ»ç´É, ƯÀÌȰ¼ºµµ
specific gravity
ºñÁß
specific phobia
ƯÁ¤°øÆ÷(Áõ)
specific
ƯÀÌ-, ƯÁ¤-
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
antiserum
Ç×Ç÷û
horse antiserum thymocyte
¸»Ç×Ç÷û°¡½¿»ù¼¼Æ÷
age-specific rate
¿¬·Éº°Æ¯¼öÀ²
age-specific death rate
¿¬·Éº°Æ¯¼ö»ç¸Á·ü
age-specific fertility rate
¿¬·Éº°Ãâ»êÀ²
granulocyte-specific antigen
°ú¸³±¸Æ¯ÀÌÇ׿ø
group-specific antigen
±ºÆ¯ÀÌÇ׿ø
organ specific antigen
Àå±âƯÀÌÇ׿ø
platelet-specific antigen
Ç÷¼ÒÆÇƯÀÌÇ׿ø
specific action
ƯÀÌÀÛ¿ë
specific activity
ºñ¹æ»ç´É, ƯÀÌȰ¼ºµµ
specific antagonist
ƯÀÌ´ëÇ×Á¦
specific antigen
ƯÀÌÇ׿ø
specific pathogen free animal
ƯÁ¤¹«º´¿øÃ¼µ¿¹°
type specific antigen
ÇüƯÀÌÇ׿ø
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
antiserum
Ç×Ç÷û
antiserum
Ç×Ç÷û(ù÷úìôè).
antiserum
Ç×Ç÷û(ù÷úìôè)
antiserum anaphylaxis
Ç×Ç÷û¾Æ³ªÇʶô½Ã.
antiserum anaphylaxis
Ç×Ç÷û¾Æ³ªÇʶô½Ã½º.
antiserum, monospecfic
´ÜÀÏÆ¯ÀÌÇ×Ç÷û
antiserum, polyvalent
´Ù°¡Ç×Ç÷û
homologous antiserum
µ¿Á¾Ç×Ç÷û.
polyvalent antiserum
´Ù°¡Ç×Ç÷û
SDA= specific dynamic action
ƯÀ̵¿Àû ÀÛ¿ë.
age specific death rate
¿¬·Éº° »ç¸Á·ü
antigen, species-specific
Á¾Æ¯ÀÌÇ׿ø
antigen, tumor-specific
Á¾¾çƯÀÌÇ׿ø
antigen, tumor-specific transplantation
Á¾¾çƯÀÌ À̽ÄÇ׿ø
antigen,tumor-specific transplantation
Á¾¾ç ƯÀÌÀ̽Ä(ðþåË ÷åì¶ì¹ãÕ)
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
antiserum
Ç×Ç÷û(ù÷úìôè).
antiserum
Ç×Ç÷û(ù÷úìôè)
antiserum
Ç×Ç÷û
antiserum anaphylaxis
Ç×Ç÷û¾Æ³ªÇʶô½Ã.
antiserum anaphylaxis
Ç×Ç÷û¾Æ³ªÇʶô½Ã½º.
antiserum, monospecfic
´ÜÀÏÆ¯ÀÌÇ×Ç÷û
antiserum, polyvalent
´Ù°¡Ç×Ç÷û
homologous antiserum
µ¿Á¾Ç×Ç÷û.
insulin antiserum
Ç×Àν¶¸°Ç÷û.
polyvalent antiserum
´Ù°¡Ç×Ç÷û
age specific death rate
¿¬·Éº° »ç¸Á·ü
antigen, species-specific
Á¾Æ¯ÀÌÇ׿ø
antigen, tumor-specific
Á¾¾çƯÀÌÇ׿ø
antigen, tumor-specific transplantation
Á¾¾çƯÀÌ À̽ÄÇ׿ø
antigen,tumor-specific transplantation
Á¾¾ç ƯÀÌÀ̽Ä(ðþåË ÷åì¶ì¹ãÕ)
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½